Komori
Treasury Stock5187CREATE MEDIC CO.,LTD.Electrical Equipment and Precision Instruments

Notice Regarding the Status of Share Repurchases

In June 2026, the company acquired 62,100 treasury shares through market purchases on the Tokyo Stock Exchange for approximately ¥67.29 million. Cumulative acquisitions since the resolution of the Board of Directors totaled 372,600 shares, with a cumulative acquisition cost of ¥428,506,800.

Worth reading
42Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
67289800
¥
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Market purchases on the Tokyo Stock Exchange

Resolved 27 March 2026 / Acquisition period 30 March 2026 to 31 October 2026

86.7%
Cumulative utilization rate
Limit
Number of Shares430,000 shares (maximum)
82.4%
Cumulative utilization rate
LimitShares 86.7%
Amount¥520,000,000 (maximum)

The darker band is the portion acquired this time (1 June 2026 to 30 June 2026). At this pace, the share-count limit will be reached first, and the acquisition will end without using the full monetary limit.

Number of Shares
Limit430,000 shares (maximum)
Cumulative total372,600 shares (through 30 June 2026)
Current62,100 shares
Amount
Limit¥520,000,000 (maximum)
Cumulative total¥428,506,800 (through 30 June 2026)
Current¥67,289,800
Average acquisition price for this transaction (calculated)¥1,084 per shareCurrent acquisition price ÷ current number of shares acquired

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction62,100 shares
Total current acquisition price¥67,289,800
Acquisition date/acquisition period1 June 2026 to 30 June 2026
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired372,600 shares (through 30 June 2026)
Cumulative acquisition cost¥428,506,800 (through 30 June 2026)
Resolution date27 March 2026
Maximum number of shares to be acquired430,000 shares (maximum)
Total acquisition price¥520,000,000 (maximum)
Acquisition period under the resolution30 March 2026 to 31 October 2026
Items this document does not state (3)
Percentage of total issued sharesWhether acquisition has been completedAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To report the status of the acquisition of treasury shares pursuant to the provisions of Article 156 of the Companies Act, as applied by replacing the relevant terms under Article 165, paragraph 3 of the same Act. No purpose for the treasury share acquisition itself is stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases | CREATE MEDIC CO.,LTD. (5187) timely disclosure | Komori